Pragyan Pharmaceuticals Private Limited

Pragyan Pharmaceuticals Private Limited - pharma in Kolar, Karnataka, India. FY 2026 financials & compliance.
CIN U74999KA2017PTC102957 Incorporated 16 May 2017 ROC Bangalore HQ Kolar, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2021
₹37.48 Lakh
▼ 28% YoY
Net loss · FY 2021
₹36,101
Net margin -1%
EBITDA · FY 2021
₹81,403
EBITDA margin 2.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Pragyan Pharmaceuticals Private Limited

Data last updated:

Pragyan Pharmaceuticals Private Limited is a private limited company based in Kolar, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2017PTC102957. Its GSTIN is 29AAJCP1872F1Z6 (Karnataka).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manjunatha Jayaram and Jayaramu Madhusudhana.

Its last annual general meeting (AGM) was held on 15 January 2022, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Jayaramnilaya W – 25 Keelukote, Kolar, Karnataka, India – 563101.

As per the financials filed for FY 2021, the company reported a revenue of ₹37.48 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹36,101 (net margin -1%) and EBITDA of ₹81,403 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.

Court records list 1 case involving the company, including 1 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999KA2017PTC102957
Registration Number 102957
Incorporation Date 16 May 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 January 2022
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant

Contact details

Pragyan Pharmaceuticals Private Limited's registered office is in Kolar, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Jayaramnilaya W – 25 Keelukote, Kolar, Karnataka, India – 563101
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Pragyan Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Pragyan Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pragyan Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Pragyan Pharmaceuticals Private Limited, buy the company report.

Financials of Pragyan Pharmaceuticals Private Limited

FY 2021 filings available

Pragyan Pharmaceuticals Private Limited reported revenue of ₹37.48 Lakh (down 28% YoY) for FY 2021.

Revenue · FY 2021
₹37.48 Lakh ▼ 28%
Net loss · FY 2021
₹36,101 margin -1%
EBITDA · FY 2021
₹81,403 margin 2.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 159%
3 years · compounded
▲ 30%

Revenue fell 28% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 45%. EBITDA rose 159% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹81,403
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹36,101
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin2.2%
Net Profit Margin-1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pragyan Pharmaceuticals Private Limited, buy the company report.

Board of directors of Pragyan Pharmaceuticals Private Limited

Pragyan Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Manjunatha JayaramDirector16 May 20179 Years 5 MonthsCurrent
Jayaramu MadhusudhanaDirector16 May 20179 Years 5 MonthsCurrent

Peer comparison

Pragyan Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Crest Pharma Private Limited₹37.53 Lakh (FY 2023)-13.0%Patna, Bihar, India
Alletia Remedies Private Limited₹37.48 Lakh (FY 2024)-19.0%Delhi, India
Pragyan Pharmaceuticals Private Limitedthis company₹37.48 Lakh (FY 2021)-₹36,101-1%-28.0%Kolar, Karnataka, India
Ovia Pharma Private Limited₹37.48 Lakh (FY 2022)41.0%New Delhi, Delhi, India
Aenor Pharmaceuticals Private Limited₹37.39 Lakh (FY 2024)15.0%Ambala, Haryana, India

To see the full peer comparison of Pragyan Pharmaceuticals Private Limited, buy the company report.

Auditor

Pragyan Pharmaceuticals Private Limited is audited by APEKSHA JAIN & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
APEKSHA JAIN & ASSOCIATESFY 2019017693S

Shareholding

The shareholding of Pragyan Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Pragyan Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pragyan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Pragyan Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAJCP1872F1Z6KarnatakaActive03 Aug 2017

To see the full GST registrations and return filing status of Pragyan Pharmaceuticals Private Limited, buy the company report.

Recent activity

Pragyan Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Jayaramu Madhusudhana was appointed as Director on 16 May 2017.

AGM
Pragyan Pharmaceuticals Private Limited last Annual general meeting of members was held on 15 Jan 2022 as per latest MCA records.
Filing
Pragyan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore.
Appointed
Jayaramu Madhusudhana was appointed as Director.
Appointed
Manjunatha Jayaram was appointed as Director.
Incorporation
16 May 2017
Pragyan Pharmaceuticals Private Limited was registered on 16 May 2017 with Roc Bangalore & aged 9 years 5 months as per MCA records.

Frequently asked questions

Pragyan Pharmaceuticals is an active private limited company based in Kolar, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2017 (9+ years old) and is registered under CIN U74999KA2017PTC102957.

Pragyan Pharmaceuticals has 2 current directors:

The latest financial statements of Pragyan Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 15 January 2022. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Pragyan Pharmaceuticals is 29AAJCP1872F1Z6, registered in Karnataka.

The CIN (Corporate Identification Number) of Pragyan Pharmaceuticals is U74999KA2017PTC102957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pragyan Pharmaceuticals has 1 court case on record: 1 filed by the company.

Pragyan Pharmaceuticals was incorporated on 16 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.

The peers of Pragyan Pharmaceuticals by revenue are Crest Pharma Private Limited, Alletia Remedies Private Limited, Ovia Pharma Private Limited, Aenor Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Jayaramu Madhusudhana was appointed as Director on 16 May 2017. Manjunatha Jayaram was appointed as Director on 16 May 2017.

The registered office of Pragyan Pharmaceuticals is at Jayaramnilaya W – 25 Keelukote, Kolar, Karnataka, India – 563101.

Pragyan Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.